Cantourage Group (HIGH) Q2 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 TU earnings summary
23 Jun, 2026Executive summary
Achieved record revenue of EUR 27.9 million in Q2 2025, marking the strongest quarter in company history.
Year-to-date revenue reached EUR 54.0 million, already surpassing the full-year 2024 revenue of EUR 51.4 million.
Revenue growth exceeded 130% compared to Q2 2024 (EUR 12.0 million).
Financial highlights
Q2 2025 revenue: EUR 27.9 million, up from EUR 12.0 million in Q2 2024.
Year-to-date 2025 revenue: EUR 54.0 million, exceeding 2024's total annual revenue.
All figures are preliminary, unaudited, and unconsolidated.
Outlook and guidance
Strong demand continues in Germany and internationally, supported by expanded processing capacities and new suppliers.
Positioned for continued successful market operations due to industry partnerships.
Latest events from Cantourage Group
- Premium focus lifted Q2 EBITDA 45% YoY despite a 22% revenue decline.HIGH
Company presentation - Q3 EBITDA turned positive as higher margins and international markets offset German pricing pressure.HIGH
Q3 2026 - Profitable, asset-light cannabis platform drives growth with innovation, telemedicine, and strong margins.HIGH
Company presentation - EBITDA up 45% in Q2 2026 as high-margin focus boosts profitability and international growth.HIGH
Q2 2026 - Net profit surged to €210,989.14 in H1 2024, driven by higher revenue and one-time income.HIGH
H1 2024 - Revenue and net income grew strongly, with all earnings retained and a clean audit opinion.HIGH
H2 2024 - Q1 2025 revenue soared to EUR 25.6 million, quadrupling year-over-year on robust European demand.HIGH
Q1 2025 TU - Profitable, asset-light cannabis platform drives growth with innovation and telemedicine.HIGH
Investor presentation - Revenue and profit fell, but equity and liquidity remain robust amid higher compliance costs.HIGH
H1 2025